Three-dimensional (3D) printing: Implications for risk assessment and management in occupational settings

Annals of Work Exposures and Health​ – The widespread application of additive manufacturing (AM) technologies, commonly known as three-dimensional (3D) printing, have raised concerns regarding the possible health implications. This review evaluates available data concerning exposure assessment in workplaces and possible effects of 3D printing emissions on humans. The literature demonstrated that a significant fraction of the particles released during 3D printing could be in the ultrafine size range, and increased levels of metals and volatile organic compounds could be detected during AM operations.

Read more »

Abonnez-vous à nos bulletins

L'équipe CAREX Canada offre deux bulletins réguliers: le Bulletin électronique semestriel résumant les informations sur nos prochains webinaires, les nouvelles publications et mises à jour des estimations et des outils; et le Bulletin des actualités cancérogènes, un condensé mensuel des articles de presse, des rapports gouvernementaux, et de la littérature académique relative aux substances cancérigènes que nous avons classé comme important pour la surveillance au Canada. Inscrivez-vous à un de ces bulletins, ou les deux, ci-dessous.

CAREX Canada

School of Population and Public Health

Université de la Colombie-Britannique
Campus de Vancouver
2206 East Mall, bureau 370A
Vancouver, C.-B. V6T 1Z3​
CANADA

© 2022 CAREX Canada

Surface contamination with nine antineoplastic drugs in 109 Canadian centers; 10 years of a monitoring program

Journal of Oncology Pharmacy Practice – A cross-sectional antineoplastic monitoring program is conducted once a year with voluntary Canadian hospital centers, since 2010. Twelve standardized sampling sites were sampled in 109 hospital centers between January 31 and June 18, 2020. Cyclophosphamide and gemcitabine were the drugs most frequently quantified on the surfaces. The armrest of patient treatment chairs, the front grille inside the biological safety cabinet (BSC) and the floor in front of the BSC were frequently contaminated. This large-scale study showed reproducible long term follow up of the contamination of standardized sites of Canadian centers and a reduction in surface contamination from 2010 to 2020.

Read more »

Abonnez-vous à nos bulletins

L'équipe CAREX Canada offre deux bulletins réguliers: le Bulletin électronique semestriel résumant les informations sur nos prochains webinaires, les nouvelles publications et mises à jour des estimations et des outils; et le Bulletin des actualités cancérogènes, un condensé mensuel des articles de presse, des rapports gouvernementaux, et de la littérature académique relative aux substances cancérigènes que nous avons classé comme important pour la surveillance au Canada. Inscrivez-vous à un de ces bulletins, ou les deux, ci-dessous.

CAREX Canada

School of Population and Public Health

Université de la Colombie-Britannique
Campus de Vancouver
2206 East Mall, bureau 370A
Vancouver, C.-B. V6T 1Z3​
CANADA

© 2022 CAREX Canada

Occupational cancer burden: The contribution of exposure to process-generated substances at the workplace

Molecular Oncology – In this study, researchers illustrate how common occupational exposures are and discuss challenges in estimating their global prevalence and their contribution to the burden of occupational cancer. The population attributable fraction for lung cancer due to occupational exposure has been estimated to be between 18 and 25% in men and 2–6% in women, resulting in lung cancer being the most prevalent occupational cancer. Actions to reduce exposures and research to fill gaps in knowledge adapted to local settings are warranted to mitigate the occupational cancer burden, especially in under-researched settings including low and middle income countries.

Read more »

Abonnez-vous à nos bulletins

L'équipe CAREX Canada offre deux bulletins réguliers: le Bulletin électronique semestriel résumant les informations sur nos prochains webinaires, les nouvelles publications et mises à jour des estimations et des outils; et le Bulletin des actualités cancérogènes, un condensé mensuel des articles de presse, des rapports gouvernementaux, et de la littérature académique relative aux substances cancérigènes que nous avons classé comme important pour la surveillance au Canada. Inscrivez-vous à un de ces bulletins, ou les deux, ci-dessous.

CAREX Canada

School of Population and Public Health

Université de la Colombie-Britannique
Campus de Vancouver
2206 East Mall, bureau 370A
Vancouver, C.-B. V6T 1Z3​
CANADA

© 2022 CAREX Canada

More countries act against exposure to radon and associated cancer risks

World Health Organization – More countries than ever before are protecting health from radon exposure, but many still need to take action to mitigate the impacts of this carcinogenic radioactive gas, according to a new WHO survey. So far, a total of 56 countries – over a quarter of all WHO Member States – responded to the WHO radon survey. The vast majority have set national reference levels for homes and workplaces, 44 per cent have developed national radon action plans, and 39 per cent have included it in codes for new buildings. Globally, in 2019, residential radon exposure alone was estimated to have caused 84,000 deaths by lung cancer; in some countries, it is among the leading causes of lung cancer.

Read more »

Abonnez-vous à nos bulletins

L'équipe CAREX Canada offre deux bulletins réguliers: le Bulletin électronique semestriel résumant les informations sur nos prochains webinaires, les nouvelles publications et mises à jour des estimations et des outils; et le Bulletin des actualités cancérogènes, un condensé mensuel des articles de presse, des rapports gouvernementaux, et de la littérature académique relative aux substances cancérigènes que nous avons classé comme important pour la surveillance au Canada. Inscrivez-vous à un de ces bulletins, ou les deux, ci-dessous.

CAREX Canada

School of Population and Public Health

Université de la Colombie-Britannique
Campus de Vancouver
2206 East Mall, bureau 370A
Vancouver, C.-B. V6T 1Z3​
CANADA

© 2022 CAREX Canada